All Lots of Liptruzet in U.S. Recalled Over Packaging Defect (FREE)

By Larry Husten All lots of the combination cholesterol-lowering drug Liptruzet (ezetimibe and atorvastatin) in the U.S. are being recalled because a packaging defect could …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news